Conclusion: Invasive assessment of LF-LG AS is an alternative to accurately assess the true severity of AS and guide appropriate management to improve long term outcomes. http://dx.
Objective: To determine if STS score alone can predict which patients proceed to a TAVI procedure Method: When evaluating a patient's suitability for a TAVI procedure, Australian multidisciplinary heart teams (MDT) also assess the perioperative risk of surgical mortality (PROM). The STS PROM is calculated based on the patient demographics, history and clinical variables weighted against outcomes for surgical Atrial Valve Replacement (sAVR). However, it does not include many factors deemed important for decision of TAVI vs sAVR. The TAVI Registry commenced mandatory STS scoring in August 2018. Three STS risk levels are included in the cohort of data exported from the TAVI Registry in February 2019.
Results: Out of 677 cases in the TAVI registry with completed STS score, 274 were low risk (STS <4%), 264 "intermediate risk" (STS 4-7%) and 139 "high risk" (STS ≥8%). TAVI was performed as recommended by an MDT, indicating there are other factors which must be considered during risk assessment of patients such as: previous cardiac surgery; porcelain aorta, frailty score, mental state (dementia), mobility, social situation and BMI.
Conclusion: The majority of patients in the TAVI Registry were the "low-risk" for sAVR suggesting deficiency of using Introduction: Sex differences are increasingly recognised in clinical presentation, treatment and outcomes in acute coronary syndromes (ACS). Women are reported to have higher mortality related to percutaneous coronary intervention (PCI) than men. However, the effect of sex on long-term outcomes after PCI in Australia is unknown.
Methods: Patients with ACS undergoing PCI were stratified by sex. We evaluated 1-year mortality and rates of readmissions.
Results: Data were available for 5004 patients (24.2% women) having PCI for ACS from Nov2008 -Jan2018. Women were older (71.7 ± 11.0 vs 66.8 ± 11.2 years p < 0.001), with more hypertension (79.1% vs 69.4% p < 0.001), vessel < 2.5mm (30.8% vs 21.3% p < 0.001), AF (16.4% vs 12.8% p = 0.018) or shock (1.4% vs 0.7% p < 0.019) but lower rates of smoking (39.6% vs 61.4% p < 0.001), multivessel disease (39.5% vs 46.8% p < 0.001) or radial PCI. At 1-year women had a trend for higher rates of death and significantly greater rates of readmissions than men (aOR 1.37, 1.11-1.66, p = 0.003).
Conclusion:
Women undergoing PCI for ACS, demonstrate differing baseline characteristics and higher rates of mortality as well as readmissions at 1 year than men. This indicates a need for improved treatments for women undergoing PCI. http://dx.doi.org/10.1016/j.hlc.2019.06.644
